138 related articles for article (PubMed ID: 26352428)
1. Improved detection of diffuse large B-cell lymphoma by flow cytometric immunophenotyping-Effect of tissue disaggregation method.
Vallangeon BD; Tyer C; Williams B; Lagoo AS
Cytometry B Clin Cytom; 2016 Sep; 90(5):455-61. PubMed ID: 26352428
[TBL] [Abstract][Full Text] [Related]
2. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis.
Zaldivar RA; Martin DF; Holden JT; Grossniklaus HE
Ophthalmology; 2004 Sep; 111(9):1762-7. PubMed ID: 15350334
[TBL] [Abstract][Full Text] [Related]
3. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.
Schniederjan SD; Li S; Saxe DF; Lechowicz MJ; Lee KL; Terry PD; Mann KP
Am J Clin Pathol; 2010 May; 133(5):718-26. PubMed ID: 20395518
[TBL] [Abstract][Full Text] [Related]
4. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma?
Dunphy CH
Cytometry; 2000 Oct; 42(5):296-306. PubMed ID: 11025488
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders.
Dunphy CH; Gardner LJ; Grosso LE; Evans HL
Am J Clin Pathol; 2002 Jan; 117(1):24-8. PubMed ID: 11789726
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry.
El-Sayed AM; El-Borai MH; Bahnassy AA; El-Gerzawi SM
Diagn Pathol; 2008 Nov; 3():43. PubMed ID: 18986555
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases.
Sharara N; Holden JT; Wojno TH; Feinberg AS; Grossniklaus HE
Ophthalmology; 2003 Jun; 110(6):1245-54. PubMed ID: 12799255
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of flow cytometric immunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy.
Liu W; Medeiros LJ; Lin P; Romaguera JE; Wang SA; Jorgensen JL
Am J Clin Pathol; 2012 Apr; 137(4):634-40. PubMed ID: 22431541
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study.
Xu Y; Kroft SH; McKenna RW; Aquino DB
Br J Haematol; 2001 Mar; 112(4):945-9. PubMed ID: 11298589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
12. Combining fine-needle aspiration and flow cytometric immunophenotyping in evaluation of nodal and extranodal sites for possible lymphoma: a retrospective review.
Dunphy CH; Ramos R
Diagn Cytopathol; 1997 Mar; 16(3):200-6. PubMed ID: 9099538
[TBL] [Abstract][Full Text] [Related]
13. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
[TBL] [Abstract][Full Text] [Related]
14. Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large B-cell lymphoma.
Riondato F; Miniscalco B; Poggi A; Aricò A; Aresu L; Comazzi S; Martini V
Cytometry B Clin Cytom; 2016 Nov; 90(6):525-530. PubMed ID: 26663674
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
[TBL] [Abstract][Full Text] [Related]
18. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
19. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
20. Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies.
Wheeler M; White G; Brockie S; Dickson M; Weinkove R
Cytometry B Clin Cytom; 2018 Nov; 94(6):935-940. PubMed ID: 30350400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
